Stanton Honig, MD

Professor of Clinical Urology; Director, Male Reproductive Health Program; Director, Male Sexual Medicine Program

Research Departments & Organizations

Urology

Yale Cancer Center

General Adult Urology

Research Interests

Erectile Dysfunction; Health Services for Transgender Persons; Hypogonadism; Infertility, Male; Reproduction; Vasectomy

Extensive Research Description

novel treatments of peyronie's disease

experimental therapies (oral testosterone) in the treatment of hypogonadism.

experimental treatments of erectile dysfunction

Activities

  • Vasectomy Guidelines Course San Diego, United States (2013 - 2013)

    AUA 2013

  • Vasectomy Guidelines Course Atlanta, United States (2012 - 2012)

    AUA 2012

  • Fertility and Sexual in the Transsexual Patient Washington, United States (2012 - 2012)

    Presentation at the ASRM Chairman Symposium

  • "Vasectomy Versus Tubal Occlusion: A Cost Based Analysis for Surgical Sterilization?" Washington, United States (2011 - 2011)

    Presentation at the National AUA Annual Meeting

  • Invited speaker Mersin, Turkey (2011 - 2011)

    Turkish Andrology Society

  • "Injection Site Abscess With Unpredictable Testosterone (T) Response Is An Uncommon Complication Of Testosterone Pellet Implantation" Las Vegas, United States (2011 - 2011)

    Presentation given to the Sexual Medicine Society of North America (SMSNA)

  • Oligospermia: Benefits of Diagnosing and Treating the Male Denver, United States (2010 - 2010)

    Chairman: Interactive Session ASRM SMRU/SRS

  • "TESE in the Adolescent Klinefelter's Patient: Standard of care or Not Ready for Prime Time?" Chicago, United States (2009 - 2009)

    Presentation at the National AUA Annual Meeting

  • "Cost effective Office Based Loupe Magnification Microscopic Epididymal Sperm Aspiration (MESA) with Local Anesthesia only: Is it Safe and Efficacious?" Chicago, United States (2009 - 2009)

    Presentation at the National AUA Annual Meeting

  • Invited Lecturer Washington, United States (2009 - 2009)

    Joint Meeting SSMR/CDC-Male Reproductive Health

  • Varicoceles Chicago, United States (2009 - 2009)

    Plenary Session Moderator at the American Urological Association National Meeting

  • Advancing Male Reproductive Health Shanghai, China (2009 - 2009)

    Invited Speaker, CDC conference

  • Update on Peyronie’s Disease Washington, United States (2008 - 2008)

    Northeast Regional Symposium on Men’s and Women’s Health

  • Male Hormonal Contraception Washington, United States (2008 - 2008)

    State of the Art Lecture, SMSNA

  • "Ejaculatory Pain after Herniorraphy: Diagnostic Testing and Treatment of Vasal Obstruction with Vasectomy" Toronto, Canada (2008 - 2008)

    Presentation given to the Sexual Medicine Society of North America (SMSNA)

  • "Does Intralesional Verapamil for treatment of Peyronie's Disease affect sexual behavior in between Injections?" Toronto, Canada (2008 - 2008)

    Presentation given to the Sexual Medicine Society of North America (SMSNA)

  • "Effects of Clomiphene Citrate on PSA levels" Washington, United States (2008 - 2008)

    Presentation given to the American Society of Reproductive Medicine

  • Genito-Urological Barriers to Healthy Sexual Function Charlotte, United States (2007 - 2007)

    Key Note Speaker: American Association of Sexuality Educators, counselors and therapists (AASECT)

  • "Patients are very uninformed about male infertility: A patient partner questionnaire study" Anaheim, United States (2007 - 2007)

    Presentation at the National AUA Annual Meeting

  • Urology Grand Rounds New York City, United States (2006 - 2006)

    Montefiore Hospital

  • Roundtable Leader New Orleans, United States (2006 - 2006)

    Acute Ejaculatory Dysfunction on the Day of Oocyte Retrieval, American Society for Reproductive Medicine

  • “Relationship of Penile Curvature and Penile Vascular Status in Patients with Peyronie’s Disease” Washington, United States (2006 - 2006)

    Presentation given to the Sexual Medicine Society of North America (SMSNA)

  • “Repeat Testicular sperm extraction (TESE): Outcome, clinical correlates and complications of different intervals between first and subsequent TESE” Washington, United States (2006 - 2006)

    Presentation given to the American Society of Reproductive Medicine

  • “Anabolic Steroid associated Infertility” Washington, United States (2005 - 2005)

    Presentation given to the American Society of Reproductive Medicine

  • “Updated Epididymal Motion on Ultrasound in patients with Obstructive Azoospermia” San Francisco, United States (2004 - 2004)

    Presentation at the National AUA Annual Meeting

  • “Patients with Peyronie’s disease have significant penile sensory deficits prior to surgery” San Francisco, United States (2004 - 2004)

    Presentation at the National AUA Annual Meeting

  • “Economics of Male Infertility” Chicago, United States (2003 - 2003)

    Plenary session- State of the Art Lecture at the AUA National Meeting 2003

  • Visiting Professor Loma Linda, United States (2002 - 2002)

    Urology Grand Rounds, Loma Linda School of Medicine

  • “Alarming Tumor rate and High sperm recovery rate in cases of secondary azoospermia” Washington, United States (2002 - 2002)

    Presentation given to the American Society of Reproductive Medicine

  • Travel Award Speaker Washington, United States (2001 - 2001)

    Society Male Reproduction/Urology ASRM Meeting

  • “Testicular Microdissection techniques” Washington, United States (2001 - 2001)

    Presentation given to the American Society of Reproductive Medicine

  • “Marlex mesh induced Vasal obstruction” Washington, United States (2001 - 2001)

    Presentation given to the American Society of Reproductive Medicine

  • Roundtable discussion leader Toronto, Canada (1999 - 1999)

    American Society for Reproductive Medicine (ASRM)

  • Visiting Professor Redlands, United States (1999 - 1999)

    Department of Urology, Loma Linda University

  • Roundtable leader Washington, United States (1999 - 1999)

    ASRM Sperm Retrieval Techniques

  • “Transurethral resection of the ejaculatory ducts: Success rates, options of Repeat Resection, seminal vesicle aspiration and sperm retrieval after unsuccessful repair” Washington, United States (1999 - 1999)

    Presentation given to the American Society of Reproductive Medicine

  • “Inducible nitric oxide synthase (iNOS) activity is unregulated in the epididymis of rats with long term varicoceles” Washington, United States (1999 - 1999)

    Presentation given to the American Society of Reproductive Medicine

  • “Pathophysiology of low flow priapism: intermediate evidence of high flow defined with duplex ultrasonography” Washington, United States (1999 - 1999)

    Presentation given to the Sexual Medicine Society of North America (SMSNA)

  • “Spermatic Motion in the epididymis: A new real time ultrasonographic finding in patients with epididymal obstruction” San Diego, United States (1998 - 1998)

    Presentation at the National AUA Annual Meeting

  • MRI Findings of an Adrenal Hemangioma. Boston, United States (1998 - 1998)

    Presentation at the Countway Harvard Grand Rounds

  • Visiting Professor Springfield, United States (1998 - 1998)

    Department of Urology, Baystate Medical Center

  • Sperm Aspiration in Male Infertility Boston, United States (1998 - 1998)

    State of the Art Lecture, given to the New England Section of the AUA

  • “Geographic variability in the frequency of cystic fibrosis membrane conductance regulator gene mutations in patients presenting with congenital absence of the vas deferens” San Diego, United States (1998 - 1998)

    Presentation at the National AUA Annual Meeting

  • “E Coli lipopolysaccharide increases nitric oxide synthase and myeloperoxidase activity in a rat model” San Diego, United States (1998 - 1998)

    Presentation at the National AUA Annual Meeting

  • “Office based microscopic epididymal sperm aspiration (MESA) vs. operating room-based MESA: cost and success analysis” Washington, United States (1997 - 1997)

    Presentation given to the American Society of Reproductive Medicine

  • “Intraurethral Prostaglandin E1 as treatment of erectile dysfunction in prostate cancer patients post radical prostatectomy: review of subjective and objective results" Washington, United States (1997 - 1997)

    Presentation at the New England Section AUA Annual Meeting

  • Urology-CPT/RSRVS Committee ASRM Washington, United States (1997 - 1997)

    Society of Male Reproduction

  • “Predictability of immediate trial processing of testis versus permanent Bouin’s solution testis biopsy in patients with an obstructive azoospermia” Washington, United States (1996 - 1996)

    Presentation given to the American Society of Reproductive Medicine

  • “Fresh epididymal sperm aspiration in obstructive Azoospermia” Washington, United States (1996 - 1996)

    Presentation at the New England Section AUA Annual Meeting

  • “The role of morphometrical features in sperm selection from testicular tissue for ICSI" Washington, United States (1996 - 1996)

    Presentation given to the American Society of Reproductive Medicine

  • “When is an Azoospermic not an azoospermic?” Washington, United States (1995 - 1995)

    Presentation given to the New England Section AUA Annual Meeting

  • “Multiple sequential rectal probe ejaculation improves semen quality in anejaculatory men” San Antonio, United States (1993 - 1993)

    Presentation at the National AUA Annual Meeting

  • “Pathologic epididymal obstruction unrelated to vasectomy: Results with microsurgical repair” San Antonio, United States (1993 - 1993)

    Presentation at the National AUA Annual Meeting

  • “Transurethral resection of ejaculatory duct cysts: Comparison of results in high and low volume azoospermia/severe oligospermia” San Antonio, United States (1993 - 1993)

    Presentation at the National AUA Annual Meeting

  • “Functional characteristics of sperm after exposure to heat or electrical current generated using an in vitro electroejaculation” Washington, United States (1993 - 1993)

    Presentation given to the American Society of Reproductive Medicine

  • “Comparison of trutrak test results in fresh and post thaw donor semen samples” Washington, United States (1993 - 1993)

    Presentation given to the American Society of Reproductive Medicine

  • “Significant medical pathology (SMP) uncovered by a urologist-based male infertility evaluation” Washington, United States (1993 - 1993)

    Presentation given to the American Society of Reproductive Medicine

  • “Succesful microscopic sperm aspiration and pregnancies in patients with obstructive azoospermia/servere oligoasthenospermia” Washington, United States (1992 - 1992)

    Presentation at the National AUA Annual Meeting

  • “Use of atropine sulfate in pharmacological erections: Initial experience with one year follow-up in the United States” Washington, United States (1992 - 1992)

    Presentation at the National AUA Annual Meeting

  • “Infertility associated with unilateral congenital absence of the scrotal vas deferens accompanied by contralateral mesonephric duct anomalies: Radiological, surgical and therapeutic aspects” Washington, United States (1992 - 1992)

    Presentation at the National AUA Annual Meeting

  • “Ultrasonographic renal and seminal vesicle anomalies in patients with bilateral congenital absence of the vas deferens” Toronto, Canada (1991 - 1991)

    Presentation at the National AUA Annual Meeting

  • “Updated hemodynamic concepts in radiation-associated impotence” Toronto, Canada (1991 - 1991)

    Presentation at the National AUA Annual Meeting

  • “Rescuing the failed papaverine erection” Washington, United States (1989 - 1989)

    Presentation at the New England Section AUA Annual Meeting

  • “Pre-prostatectomy fine needle aspiration cannot differentiate Stage A1 from Stage A2 prostate cancer, but increases the overall incidence of Stage A disease” Washington, United States (1989 - 1989)

    Presentation at the New England Section AUA Annual Meeting

  • “Reduced myocardial expansion and decrease in infarct size with angiotensin-converting enzyme inhibitor, enalapril” Washington, United States (1985 - 1985)

    Presentation given to the American Society for Clinical Research

  • “Paradoxical reperfusion injury with combined angiotensin-converting enzyme inhibition and myocardial reperfusion” Washington, United States (1985 - 1985)

    Presentation given to the American Society for Clinical Research

  • “Effect of infarct size reduction with the angiotensin-converting enzyme inhibitor enalapril on early infarct expansion” Washington, United States (1985 - 1985)

    Presentation given to the American Society for Clinical Research

  • “Coronary reperfusion: Reversal of early myocardial expansion and systolic bulge” Washington, United States (1985 - 1985)

    Presentation given to the American Society for Clinical Research

  • “Reperfusion reduces early myocardial expansion” Washington, United States (1985 - 1985)

    Presenation given to the American Society for Clinical Research

  • “Correlation of traditional semen analysis with in-vitro cervical mucous penetration” Amsterdam, Netherlands (1985 - 1985)

    Presentation at the NY section AUA Annual Meeting

  • “Effects of sperm motility altering agents on penetration in cervical mucous” Amsterdam, Netherlands (1985 - 1985)

    Presentation at the NY section AUA Annual Meeting

  • “Myocardial infarct expansion: Effect of infarct size and transmurality” Washington, United States (1984 - 1984)

    Presentation given to the American Society for Clinical Research

Edit this profile